Changes in urinary potassium excretion in patients with chronic kidney disease
Yuichiro Ueda, Susumu Ookawara, Kiyonori Ito, Haruhisa Miyazawa, Yoshio Kaku, Taro Hoshino, Kaoru Tabei, Yoshiyuki Morishita
Kidney Res Clin Pract. 2016;35(2):78-83.   Published online 2016 Feb 27     DOI: https://doi.org/10.1016/j.krcp.2016.02.001
Citations to this article as recorded by Crossref logo
Potassium homeostasis and therapeutic intervention with sodium zirconium cyclosilicate: A model‐informed drug development case study
Lindsay E. Clegg, Lulu Chu, Mats Nagard, David W. Boulton, Robert C. Penland
CPT: Pharmacometrics & Systems Pharmacology.2024; 13(2): 296.     CrossRef
Postnatal persistence of nonhuman primate sex‐dependent renal structural and molecular changes programmed by intrauterine growth restriction
Andrew C. Bishop, Kimberly D. Spradling‐Reeves, Robert E. Shade, Kenneth J. Lange, Shifra Birnbaum, Kristin Favela, Edward J. Dick, Mark J. Nijland, Cun Li, Peter W. Nathanielsz, Laura A. Cox
Journal of Medical Primatology.2022; 51(6): 329.     CrossRef
La sabiduría del riñón III. La adaptación de la función renal a su daño progresivo. Hipótesis de la nefrona intacta
José Carlos Peña Rodríguez
Acta Médica Grupo Ángeles.2022; 20(2): 207.     CrossRef
Lethal ventricular arrhythmia can be prevented by adjusting the dialysate potassium concentration and the use of anti-arrhythmic agents: a case report and literature review
Takayuki Uchida, Susumu Ookawara, Kiyonori Ito, Hitomi Okada, Hideyuki Hayasaka, Masaya Kofuji, Masahiko Kimura, Yuichiro Ueda, Tadashi Hasebe, Naoki Momose, Yoshiyuki Morishita
Renal Replacement Therapy.2022;[Epub]     CrossRef
Estimation of Potassium Changes Following Potassium Supplements in Hypokalemic Critically Ill Adult Patients–A Patient Personalized Practical Treatment Formula
Amit Frenkel, Lior Hassan, Adi Segal, Adir Israeli, Yair Binyamin, Alexander Zlotnik, Victor Novack, Moti Klein
Journal of Clinical Medicine.2021; 10(9): 1986.     CrossRef
Chronic kidney disease measures for cardiovascular risk prediction
Yejin Mok, Shoshana H. Ballew, Kunihiro Matsushita
Atherosclerosis.2021; 335: 110.     CrossRef
Association between the urinary sodium-to-potassium ratio and renal outcomes in patients with chronic kidney disease: a prospective cohort study
Yuta Matsukuma, Masaru Nakayama, Susumu Tsuda, Akiko Fukui, Ryota Yoshitomi, Kazuhiko Tsuruya, Toshiaki Nakano, Takanari Kitazono
Hypertension Research.2021; 44(11): 1492.     CrossRef
Management of hyperkalaemia in acute kidney injury in a heart failure patient with patiromer
Jonathan Slawik, Juliane Dederer, Ingrid Kindermann, Michael Böhm
ESC Heart Failure.2020; 7(5): 3161.     CrossRef
Dietary Potassium Intake and Risk of Chronic Kidney Disease Progression in Predialysis Patients with Chronic Kidney Disease: A Systematic Review
Kelly Picard, Maria Ines Barreto Silva, Diana Mager, Caroline Richard
Advances in Nutrition.2020; 11(4): 1002.     CrossRef
Comparison of fractional excretion of electrolytes in patients at different stages of chronic kidney disease
Po-Jen Hsiao, Chen-Yi Liao, Yung-Hsi Kao, Jenq-Shyong Chan, Yuh-Feng Lin, Chih-Pin Chuu, Jin-Shuen Chen
Medicine.2020; 99(2): e18709.     CrossRef
Pharmacologic Treatment of Chronic Hyperkalemia in Patients with Chronic Kidney Disease
Gheun-Ho Kim
Electrolytes & Blood Pressure.2019; 17(1): 1.     CrossRef
How Do Kidneys Adapt to a Deficit or Loss in Nephron Number?
Hadi Fattah, Anita Layton, Volker Vallon
Physiology.2019; 34(3): 189.     CrossRef
Association between Urinary Calcium Excretion and Estimated Glomerular Filtration Rate Decline in Patients with Type 2 Diabetes Mellitus: A Retrospective Single-center Observational Study
Hodaka Yamada, Shunsuke Funazaki, Daisuke Suzuki, Rika Saikawa, Masashi Yoshida, Masafumi Kakei, San-e Ishikawa, Yoshiyuki Morisita, Kazuo Hara
Journal of Clinical Medicine.2018; 7(7): 171.     CrossRef
Long-term efficacy of oral calcium polystyrene sulfonate for hyperkalemia in CKD patients
Mi-Yeon Yu, Jee Hyun Yeo, Joon-Sung Park, Chang Hwa Lee, Gheun-Ho Kim, Tatsuo Shimosawa
PLOS ONE.2017; 12(3): e0173542.     CrossRef
Bromide supplementation exacerbated the renal dysfunction, injury and fibrosis in a mouse model of Alport syndrome
Tsubasa Yokota, Kohei Omachi, Mary Ann Suico, Haruka Kojima, Misato Kamura, Keisuke Teramoto, Shota Kaseda, Jun Kuwazuru, Tsuyoshi Shuto, Hirofumi Kai, Prasun K. Datta
PLOS ONE.2017; 12(9): e0183959.     CrossRef